Several new studies presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI) underscore the complex ways that HIV risk and treatment adherence manifest among women of childbearing age.
Researchers at this year's Conference on Retroviruses and Opportunistic Infections (CROI) presented their findings on the ongoing challenges of treating hepatitis C infection among people with HIV.
Reassuring data that the initial loss in bone mineral density during the first year of antiretroviral therapy slowed during subsequent years.
This year's Conference on Retroviruses and Opportunistic Infections broadened its lens from the lab to the ways that different strategies are, or might, have an impact in the context of people's complex lives.
Panelists at CROI 2018 painted a bleak picture of the scale of the country's addiction crisis, noting that the never-before-seen dynamics of the current drug epidemic require creative approaches to HIV treatment and prevention among people who inject...
A large case-control analysis reported an overall association between statin use and a reduced risk of virus-mediated cancers in HIV-positive people.
When is a pre-exposure prophylaxis (PrEP) failure actually a provider failure? And how do we tell the difference?
Gina Brown, M.D., shares her reflections on some of the many research findings about HIV prevention, care, and treatment for women and girls presented at CROI 2018.
The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.